Harvard Pulmonary and Critical Care Medicine 2023

Description

This comprehensive course provides education and updates to optimize your care of patients with:

Post-acute sequelae of COVID-19
Chronic cough
COPD
Asthma
Lung nodules
Lung cancer
Sleep-disordered breathing
GERD
Sepsis
ARDS
Sarcoidosis
IPF
Pleural disease
Pneumonia
Tuberculosis
Surgical emergencies
Thromboembolism
Lung transplantation
Neurologic issues in the ICU
Septic shock
Interstitial lung disease
Bronchiectasis
Cystic fibrosis
Atypical mycobacterial disease
Pulmonary hypertension
Cardiopulmonary disorders
Complications from cardiac arrest
Hypersensitivity pneumonitis
Occupational and environmental lung disease
Acute respiratory failure
Vaping-related lung disease
Hemorrhage and ANCA-associated disease

REASONS TO ATTEND IN 2023

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

COVID-19, PASC, and emerging diseases
Advanced techniques in interventional pulmonology
High-flow oxygen therapy for respiratory failure
New biologics for asthma
Lung microbiome: emerging implications for lung health
Emerging evidence for targeted temperature management
Evaluating occupational and environmental lung disease
Prescribing medications for interstitial lung disease
Pulmonary embolus: the latest treatment strategies
State-of-the-art management of the critically ill patient
Guidance to conduct end-of-life discussions
Updates in pulmonary pathology
New treatment options in cystic fibrosis
Handling neurologic and surgical emergencies in the medical ICU
The state of the art in interventional bronchoscopy
The most current guidelines for treating sepsis
Evidence-based treatment of ARDS
Updates on vaping-related lung disease
New therapeutics in the age of immunology
Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
New approaches that improve outcomes for patients with unexplained chronic cough
Current guidelines for management of pulmonary nodules
Targeted therapies and immunotherapies for lung cancer
When to consider lung transplantation and eligibility
When and how to use the newest drugs in IPF
Expert advice on atypical mycobacterial diagnostics and therapy
New concepts in the use of vasopressors in septic shock
New drugs and combinations in pulmonary hypertension
New evidence on sedation, analgesia, and early mobility
Point-of-care pulmonary ultrasound in the intensive care unit